JOHN BURNS: Open Payments
NPI 1326151721 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 58 payments from 12 companies in 2025. Trend: 2023 $654 · 2024 $1,863 · 2025 $1,351
Food & beverage: $1,242Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $337 |
| GENZYME CORPORATION | 4 | $264 |
| Janssen Biotech, Inc. | 14 | $242 |
| Regeneron Healthcare Solutions, Inc. | 4 | $183 |
| LEO Pharma Inc. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| UCB, Inc. | 2 | $32 |
| Galderma Laboratories, L.P. | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, ADBRY, Sotyktu, Bimzelx, Rhapsido.
Industry payments across WA — which companies pay providers there.
